COVID-19 outbreak impact on urolithiasis treatments: A multicenter retrospective study across 9 urological centers

Author:

Mazzon Giorgio1,Ferretti Stefania2,Serafin Emanuele3,Claps Francesco4,Acquati Pietro5,Brusa Davide3,Germinale Federico6,Celentano Giuseppe7,Pescuma Andrea8,Fugini Andrea Vismara9,Campobasso Davide2,Maestroni Umberto2,Costa Giovanni1,Morena Tonino9,Di Marco Flavia4,Baudo Andrea5,Creta Massimiliano7,Pavan Nicola10,Ticonosco Marco8,Peroni Angelo9,Collura Devis6,Cerruto Maria Angela3,Antonelli Alessandro3,Carmignani Luca5,Micali Salvatore8,Trombetta Carlo4,Muto Giovanni6,Celia Antonio1

Affiliation:

1. Department of Urology, AULSS7 Pedemontana, San Bassiano Hospital, Bassano del Grappa, Italy

2. Department of Urology, University Hospital of Pama, Parma, Italy

3. Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy

4. Urological Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy

5. Department of Urology, IRCCS Policlinico San Donato, Milan, Italy

6. Department of Urology, Humanitas Gradenigo Hospital, Turin, Italy

7. Department of Neurosciences, Reproductive and Oral Sciences, University of Naples Federico II, Naples, Italy

8. Urology Department, University of Modena & Reggio Emilia, Modena, Italy

9. Department of Urology, Poliambulanza Foundation Hospital, Brescia, Italy

10. Urology Section, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy

Abstract

Abstract Background The coronavirus disease (COVID-19) pandemic has posed challenges to the global health care community, affecting the management of upper urinary tract stones. Materials and methods This retrospective study involved 9 Italian centers. We compared the 12-month period prior to COVID-19 (March 1, 2019, to February 28, 2020; Period A) with the COVID-19 period (March 1, 2020, to February 28, 2021, Period B). This study aimed to compare outcomes during Periods A and B, specifically focusing on the overall number of treatments, rate of urgent/elective cases, and operational complexity. Results A total of 4018 procedures were collected, comprising 2176 procedures during Period A and 1842 during Period B, indicating a loss of 15.35% (p < 0.001). In the elective cases, 1622 procedures were conducted in Period A, compared with 1280 in Period B, representing a 21.09% reduction in cases (p = 0.001). All types of stone treatments were affected: extracorporeal shock wave lithotripsy (−29.37%, p = 0.001), percutaneous nephrolithotomy (−26.47%, p = 0.008), retrograde surgeries for renal stones (−10.63%, p = 0.008), and semirigid ureterolithotripsy (−24.86%, p = 0.008). Waiting lists experienced significant delays during Period B. The waiting time for elective procedures increased during Period B (p < 0.001). For ureteral stones, the mean waiting time in Period A was 61.44 days compared with 86.56 days in Period B (p = 0.008). The waiting time for renal stones increased from 64.96 days in Period A to 85.66 days in Period B for retrograde intrarenal surgery (p = 0.008) and from 96.9 days to 1103.9 days (p = 0.035) for percutaneous nephrolithotomy procedures. Conclusions Our study demonstrates that COVID-19 significantly disrupted endourological services across the country. Our data underline how patients received treatment over a prolonged period, potentially increasing the risk of stone-related complications and patient discomfort.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference26 articles.

1. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19);Int J Surg,2020

2. WHO declares COVID-19 a pandemic;Acta Biomed,2020

3. The response of Milan's emergency medical system to the COVID-19 outbreak in Italy;Lancet,2020

4. The impact of COVID-19 on European health care and urology trainees;Eur Urol,2020

5. Urology practice during the COVID-19 pandemic;Minerva Urol Nefrol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3